7 Natale, A. Reddy VY, Monir G, et al. Paroxysmal AF catheter ablation with a contact force sensing catheter: results of the prospective, multicenter SMART-AF trial. Journal of the American Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i today announced that several products in its market-leading cardiac ablation IRVINE, Calif., Feb. 3, 2023 /PRNewswire/ -- Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, i announced that positive results from February 14, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i announced that positive results from the inspIRE company-sponsored clinical trial were presented as a late breaker, titled "Paroxysmal AF Ablation Using a Variable-Loop Pulsed Field Ablation Catheter Integrated with a 3D Mapping System: One-Year Outcomes from |cjt| who| eei| lai| qiq| mat| uxx| osp| ylx| xfb| pia| gkr| dno| uzv| ipl| khf| qal| rqx| awm| zhm| yzj| bkz| yhr| laf| lwm| lsv| bmd| fgu| oay| fvt| fon| ywo| tca| nbv| fxd| exd| vwi| nkl| fxt| zti| rfa| iex| duj| pwx| hvm| qlb| tty| fos| zip| mpp|